Pleiotropic functions of plasminogen activator inhibitor-1.
about
The omptins of Yersinia pestis and Salmonella enterica cleave the reactive center loop of plasminogen activator inhibitor 1Fibrinolytic and coagulative activities of Yersinia pestisThe prothrombotic tendency in metabolic syndrome: focus on the potential mechanisms involved in impaired haemostasis and fibrinolytic balanceRole of adipokines in atherosclerosis: interferences with cardiovascular complications in rheumatic diseasesElevated urinary urea by high-protein diet could be one of the inducements of bladder disordersDual role for plasminogen activator inhibitor type 1 as soluble and as matricellular regulator of epithelial alveolar cell wound healingRecombinant PAI-1 therapy restores myoendothelial junctions and erectile function in PAI-1-deficient mice.Genome-wide association study for circulating levels of PAI-1 provides novel insights into its regulationA novel mRNA binding protein complex promotes localized plasminogen activator inhibitor-1 accumulation at the myoendothelial junction.Plasminogen activator inhibitor-1 regulates myoendothelial junction formation.Transgenic over-expression of plasminogen activator inhibitor-1 results in age-dependent and gender-specific increases in bone strength and mineralization.Molecular imaging of vessels in mouse models of disease.Characterization of human mesenchymal stem cell secretome at early steps of adipocyte and osteoblast differentiation.The study of t-PA, u-PA and PAI-1 genes polymorphisms in patients with abdominal aortic aneurysm.Leptin upregulates the expression of plasminogen activator inhibitor-1 in human vascular endothelial cells.Prevalence of subclinical atherosclerosis is increased in systemic sclerosis and is associated with serum proteins: a cross-sectional, controlled study of carotid ultrasoundPAI-1 leads to G1-phase cell-cycle progression through cyclin D3/cdk4/6 upregulationBrain perihematoma genomic profile following spontaneous human intracerebral hemorrhageBlueberry phytochemicals inhibit growth and metastatic potential of MDA-MB-231 breast cancer cells through modulation of the phosphatidylinositol 3-kinase pathway.Molecular signature of mineralocorticoid receptor signaling in cardiomyocytes: from cultured cells to mouse heartPlasminogen activator inhibitor-1 (PAI-1): a key factor linking fibrinolysis and age-related subclinical and clinical conditionsA non-lethal traumatic/hemorrhagic insult strongly modulates the compartment-specific PAI-1 response in the subsequent polymicrobial sepsis.Association of plasminogen activator inhibitor-1 and tissue plasminogen activator with type 2 diabetes and metabolic syndrome in Malaysian subjectsThe diuretic torasemide does not prevent aldosterone-mediated mineralocorticoid receptor activation in cardiomyocytes.Early gestation chorionic villi-derived stromal cells for fetal tissue engineeringEffect of biofilms on recalcitrance of staphylococcal joint infection to antibiotic treatment.Pancreas recovery following cerulein-induced pancreatitis is impaired in plasminogen-deficient mice.Podocyte injury-driven intracapillary plasminogen activator inhibitor type 1 accelerates podocyte loss via uPAR-mediated β1-integrin endocytosis.The vitronectin-binding function of PAI-1 exacerbates lung fibrosis in mice.Plasminogen activator inhibitor-1 4G/5G polymorphism is associated with metabolic syndrome parameters in Malaysian subjects.Critical role of type 1 plasminogen activator inhibitor (PAI-1) in early host defense against nontypeable Haemophilus influenzae (NTHi) infection.Göttingen minipig model of diet-induced atherosclerosis: influence of mild streptozotocin-induced diabetes on lesion severity and markers of inflammation evaluated in obese, obese and diabetic, and lean control animalsIntracellular Expression of PAI-1 Specific Aptamers Alters Breast Cancer Cell Migration, Invasion and Angiogenesis.Plasmin triggers a switch-like decrease in thrombospondin-dependent activation of TGF-β1.Anti-inflammatory properties of sirtuin 6 in human umbilical vein endothelial cellsFibrinolytic activity and platelet function in subjects with obstructive sleep apnoea and a patent foramen ovale: is there an option for prevention of ischaemic stroke?Therapeutic potential of an orally effective small molecule inhibitor of plasminogen activator inhibitor for asthma.Plasminogen activator inhibitor-1 as a potential marker for the malignancy of colorectal cancer.Role of the fibrinolytic and matrix metalloproteinase systems in development of adipose tissue.The role of plasminogen activator inhibitor-1 in gastric mucosal protection
P2860
Q24612107-7F3A8D90-3A0C-40FA-B6CA-9394CD8BB914Q26862503-AD42349D-E0CB-4CB4-B2DF-58DB58EFEF44Q27003277-D250F378-0894-4994-84A2-5C7D01083F91Q27008359-81127644-4F4B-4BDF-BADC-F268BD62A61AQ28573682-15A6BB27-D42A-48C6-BDCD-31CD91C541B8Q28580473-D91F6377-8AD7-441D-9865-9839CD649A5BQ30301012-163A35EE-FA4F-4323-B037-E41DC62C548EQ30415902-9F9B5F5E-6144-485F-B1E8-52081313050BQ30419477-31D3449E-8941-4A21-90A2-87E76389C0B0Q30436548-E5526FD2-8C31-445E-A77A-D1AF02010A1BQ30442725-B1511E14-9522-4CAC-AF2D-3142DBB03488Q30481645-602C92C6-E360-4099-A1F0-326AC9AB85C2Q33321325-406585BD-E5B2-4026-ABA1-502DBFD15D2CQ33579837-336BEF07-010E-4C68-8D86-FE3DA2BA42F6Q33700633-3421874C-5DBB-48D7-A4EC-45C4DC61F46BQ33704086-D0DA18F0-AE4C-4DCE-B170-563708BFE608Q33782164-665FA68F-9284-4A02-BB2C-A06EF3084527Q33818147-62BDF2DF-78E5-4B56-A046-7876C7E6409CQ33820727-7255A29B-D6F8-46DF-B307-B8FD7BCD1EE5Q34132351-B5CCDB6C-2382-46A8-86B7-B625AFBB5043Q34217461-7994846C-BB19-499F-BF50-08BA49CFC32CQ34586083-484D1EC8-DCA9-4FFD-9DC4-49A60A20253EQ34722566-8509C65E-1F33-45F3-9724-0BC6570BDC9CQ34989217-BFC61557-8652-430F-BFA3-C81A5B25E1CAQ34992001-D02319B7-9D50-4A7E-9F96-0A583E42694BQ35055203-80DA8C63-24D8-4601-B28F-5BC1B7F621C6Q35130515-1512D3D4-6E4E-4665-823F-BC79BFB46DA0Q35178613-FA20A58E-BAEF-4F53-8B22-C2E44D74465AQ35182731-09D811C2-67B1-4D3C-869F-76BFFB0C73E8Q35906917-9A61FF23-ABA6-4D1B-B63D-27A0E03FC05AQ35990134-B9AC8F00-D5AA-49F3-A054-DB37B2844503Q36086591-9A03B6ED-1155-479F-A211-D956A51D947DQ36166157-537358C8-1A35-4BEC-A646-2EC5D6E3F5F9Q36207999-F6F67B24-E418-467D-AA48-D2BE253680D1Q36364263-AE2F1A64-80AD-4017-9443-1C42132B083EQ36436224-CCAA4FCC-4E4C-4977-A5F3-C2DB6E144420Q36583859-B35D4FA5-A1AB-4CF0-BD60-CFF52189A604Q36615378-7049B826-95E3-47FF-9B1A-CFE899274C1EQ36687953-A78367D4-7D0C-4C2A-ABF0-B93B7B668CA6Q36837664-271EE735-CB76-404E-B96B-C71991B541AD
P2860
Pleiotropic functions of plasminogen activator inhibitor-1.
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Pleiotropic functions of plasminogen activator inhibitor-1.
@ast
Pleiotropic functions of plasminogen activator inhibitor-1.
@en
type
label
Pleiotropic functions of plasminogen activator inhibitor-1.
@ast
Pleiotropic functions of plasminogen activator inhibitor-1.
@en
prefLabel
Pleiotropic functions of plasminogen activator inhibitor-1.
@ast
Pleiotropic functions of plasminogen activator inhibitor-1.
@en
P2860
P1476
Pleiotropic functions of plasminogen activator inhibitor-1.
@en
P2093
P2860
P356
10.1111/J.1538-7836.2004.00827.X
P577
2005-01-01T00:00:00Z